Amneal Pharmaceuticals, Inc Class A Common Stock Financials

Values in thousands	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	$814,319	$784,513	$724,508	$695,420
Gross Profit	297,190	273,974	286,253	255,891
EBITDA	160,699	111,664	176,925	154,584
EBIT	111,472	57,591	116,812	94,425
Net Income	35,076	2,369	22,417	12,195
Net Change In Cash	814,319	784,513	724,508	695,420
Free Cash Flow	87,146	103,400	57,317	-10,914
Cash	310,871	201,249	81,186	59,187
Basic Shares	324,805	324,754	322,363	323,961

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$3,018,760	$2,793,957	$2,393,607	$2,212,304
Gross Profit	1,136,092	1,020,438	863,869	791,461
EBITDA	603,872	439,773	500,782	440,208
EBIT	380,300	203,582	271,382	200,033
Net Income	72,057	-116,886	-83,993	-129,985
Net Change In Cash	3,018,760	2,793,957	2,393,607	2,212,304
Cost of Revenue				-215,829
Free Cash Flow	269,929	220,109	276,388	-25,495
Cash	310,871	110,552	91,542	25,976
Basic Shares	324,805	308,978	176,136	150,944